Long acting human interferon analogs

Details Long acting human interferon analogs Long acting human interferon analogs

2004-05-24

2009-08-11

Sajjadi, Fereydoun G (Department: 1633)

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

C424S192100, C424S085100, C536S023520

Reexamination Certificate

active

07572437

ABSTRACT:
Compositions, kits and methods are provided for Interferon analogs in order to promote general health or for therapeutic treatment of diseases. Human interferon analogs are made by fusion of interferon with human serum albumin. The bio-assay shows that the interferon analogs with the same cell protection against viral attack have 3-10 times longer acting function than interferon in vivo. These novel long acting interferon analogs can be used in treatment of patients with viral infection, such as SARS virus, HIV, HCV, HBV, or HAV, and the cancer diseases, such as leukemia and malignant melanoma. They also have a 3-5 times longer shelf-life compared with interferon.

Affiliated with

Also associated with

Rating

Long acting human interferon analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long acting human interferon analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting human interferon analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4085281